AUSTIN (KXAN) — Advocates for HIV prevention are calling a newly approved injectable medication a major step in eliminating the spread of the virus. This summer, the FDA approved Gilead’s lenacapavir, ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV. Gilead Sciences, maker of the drug, ...

Lenacapavir, a long-acting injectable PrEP, requires two injections annually, marking a significant advancement in HIV ...

A clinical trial has found an injectable HIV treatment could be an effective prevention for the infection, NPR reported July 3. A clinical trial by drugmaker Gilead conducted a randomized study on ...

Jessica Haberer has been a consultant for Merck and the US Centers for Disease Control and Prevention. She has been an investigator in studies with drug donation from Gilead and Viiv. She has received ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Only two people taking twice-yearly lenacapavir in a ...

A twice yearly injection that is highly effective in preventing HIV transmission could dramatically reduce infections and save lives — if the people who would most benefit from the drug can obtain it, ...

The Food and Drug Administration on Wednesday approved Gilead's twice-yearly antiviral injection for preventing HIV — a milestone that the company and some experts say could help bring the world ...

Doctors at DAP Health have begun administering a new twice-a-year injectable HIV prevention medication, which was approved by the Food and Drug Administration in June. Gilead's drug lenacapavir ...